Pediatrix Medical (MD) Debt to Equity (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Debt to Equity data on file, last reported at $0.67 in Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.67, down 13.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.67 (down 13.38% YoY), and the FY2025 annual result was $0.69, down 14.56% from the prior year.
• Debt to Equity fell to $0.67 in Q1 2026 per MD's latest filing, from $0.69 in the prior quarter.
• Over five years, Debt to Equity peaked at $0.89 in Q2 2024 and troughed at $0.06 in Q2 2023.
• A 5-year average of $0.53 and a median of $0.68 in 2025 frame the typical range for Debt to Equity.
• On a YoY basis, Debt to Equity climbed as much as 26042.66% in 2022 and fell as far as 89.2% in 2022.
• A 5-year view of Debt to Equity shows it stood at $0.73 in 2022, then climbed by 2.75% to $0.75 in 2023, then gained by 8.25% to $0.81 in 2024, then slipped by 14.56% to $0.69 in 2025, then retreated by 2.53% to $0.67 in 2026.
• Business Quant data shows MD's Debt to Equity at $0.67 in Q1 2026, $0.69 in Q4 2025, and $0.68 in Q3 2025.